Publication:
Diminished ovarian reserve versus ovarian aging: overlaps and differences

dc.contributor.coauthorSeyhan, Ayşe
dc.contributor.coauthorSeli, Emre
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorAta, Mustafa Barış
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:27:18Z
dc.date.issued2019
dc.description.abstractPurpose of review Diminished ovarian reserve, in general, implies a quantitative decline in the oocyte pool. However, whether this quantitative decline is necessarily accompanied by a qualitative decline, remains to be determined. Recent findings Studies of natural conception suggest that fecundity of women with a quantitative decline in ovarian reserve is similar to age-matched women with normal ovarian reserve. Data on rates of pregnancy loss and fetal chromosomal abnormality do not consistently suggest a decline in oocyte quality in women who has a lower ovarian reserve. In assisted reproductive technology (ART) cycles, oocytes from women with diminished ovarian reserve have similar potential for euploid blastocyst development. Likewise, available evidence does not strongly suggest an increased risk of pregnancy loss in women with diminished reserve undergoing ART treatment as compared with similarly aged woman with normal ovarian reserve. Summary Quantitative decline in ovarian reserve may not be necessarily accompanied by a qualitative decline. Although a decreased number of follicles and poor response to ovarian stimulation are hallmarks of ovarian aging, younger women with diminished ovarian reserve may not be experiencing the distinct effects of aging on oocyte quality.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue3
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipFoundation for Embryonic Competence E.S. is a consultant and receives research funding from the Foundation for Embryonic Competence.
dc.description.volume31
dc.identifier.doi10.1097/GCO.0000000000000536
dc.identifier.eissn1473-656X
dc.identifier.issn1040-872X
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85065546605
dc.identifier.urihttps://doi.org/10.1097/GCO.0000000000000536
dc.identifier.urihttps://hdl.handle.net/20.500.14288/11681
dc.identifier.wos480728300001
dc.keywordsAssisted reproduction
dc.keywordsFecundity
dc.keywordsOvarian aging
dc.keywordsOvarian reserve
dc.keywordsPregnancy loss
dc.keywordsPreimplantation genetic testing follicle-stimulating-hormone
dc.keywordsAnti-mulerian hormone
dc.keywordsIn-vitro fertilization
dc.keywordsAntimullerian hormone
dc.keywordsPregnancy loss
dc.keywordsWomen
dc.keywordsAge
dc.keywordsAssociation
dc.keywordsAneuploidy
dc.keywordsBlastocysts
dc.language.isoeng
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofCurrent Opinion in Obstetrics Gynecology
dc.subjectObstetrics
dc.subjectGynecology
dc.titleDiminished ovarian reserve versus ovarian aging: overlaps and differences
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorAta, Mustafa Barış
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files